Kabi Holds To US Prices Even As Injectables Volumes Slip

 
• By Aidan Fry

Fresenius Kabi is comfortable with foregoing some volumes in the US generic injectables arena to protect prices and margins. But it is ready to cut prices if the competitive supply situation shifts.

Dollars
Fresenius Kabi is determined to hold stable its prices for US generic injectables, even if it means sacrificing some volume • Source: Shutterstock

More from Earnings

More from Business